2022-11-16
Molecular pathology and clinical treatment of primary serous carcinoma of the uterine cervix: A case report
2022-11-16 • Li‐na Niu, Fangying Ruan, Qisheng Yang, Chaoran Xia, Bifeng Zhang, Tao Xu, Fei Dong, Lizhen Zhang, Sheng Guo, Weiqin Lv, Junxia Wang, Shang Yun
A 69 years old Chinese female patient presented with independent HPV serous carcinoma uterine cervix. The genetic testing identified gene variants of PAX8 and TP53, microsatellite instability stable, TMB 7.33Muts/Mb. The patient had a good response to Docetaxel, carboplatin, and radiation with 18 months of free disease survival.